Skip to main content

Kamada Ltd

KMDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001567529

In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Kamada Ltd changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of KMDA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders5347−6
Shares7.78M7.69M−94.4K (−1.2%)
Value$45.4M$40.7M−$4.67M (−10.3%)

New holders (3)

Institutions that held Kamada Ltd at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to KMDA in Q3 2021
InstitutionSharesValue% of portfolio
Susquehanna International Group Ltd.26,658$141.0K0.03%
Susquehanna International Group, LLP23,934$127.0K0.00%
Strategic Asset Management, LLC1,000$5.00K0.01%

Sold out (9)

Institutions that held Kamada Ltd at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of KMDA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Legato Capital Management LLC47,682$278.0K
D. E. Shaw & Co., Inc.22,145$129.0K
Noked Capital LTD16,748$97.0K
Noked Israel Ltd16,748$97.0K
HRT Financial LP15,887$92.0K
UBS Group AG14,075$82.0K
Millennium Management LLC12,478$73.0K
Advisory Services Network, LLC1,583$9.00K
Mirae Asset Global Investments Co., Ltd.727$4.00K